Valuation: Exalt Resources Ltd

Market Cap 7.66M 5.39M 4.73M 4.45M 4.07M 7.6M 516M 53.43M 20.71M 263M 20.25M 19.8M 854M P/E 2025
-0.76x
P/E 2026 -1.76x
Enterprise Value -1.74M -1.23M -1.08M -1.01M -925K -1.73M -118M -12.16M -4.71M -59.91M -4.61M -4.51M -194M EV / Sales 2025
0.92x
EV / Sales 2026 -0.05x
Free-Float
61.71%
Yield 2025 *
-
Yield 2026 -
Manager TitleAgeSince
Chief Executive Officer 46 06/11/2025
Chief Tech/Sci/R&D Officer - 29/06/2020
Corporate Secretary - 12/04/2026
Director TitleAgeSince
Director/Board Member - 09/08/2021
Chairman 67 31/03/2025
Director/Board Member 46 06/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
+0.53%+2.21%-2.90%+33.28% 43.84B
+1.46%-3.28%-46.75%+129.91% 11.87B
+1.58%-6.37%-9.32%+110.75% 5.42B
+1.89%-1.88%+32.12% - 4.12B
-1.30%+5.36% - - 2.12B
-0.11%+1.73%+6.42%-33.78% 1.5B
+0.38%-0.98%-36.74% - 1B
-0.31%-3.96%+8.74%+151.30% 960M
-2.86%-4.26%+36.97%+44.33% 869M
Average +0.15%-0.80%-1.43%+72.63% 7.97B
Weighted average by Cap. +0.73%+0.54%-8.43%+57.92%

Financials

2025 2026
Net sales 62.99M 44.36M 38.94M 36.6M 33.46M 62.53M 4.25B 440M 170M 2.17B 167M 163M 7.02B 33.96M 23.91M 20.99M 19.73M 18.04M 33.71M 2.29B 237M 91.87M 1.17B 89.81M 87.84M 3.79B
Net income -60.21M -42.4M -37.22M -34.98M -31.98M -59.77M -4.06B -420M -163M -2.07B -159M -156M -6.71B -4.31M -3.03M -2.66M -2.5M -2.29M -4.28M -291M -30.07M -11.66M -148M -11.4M -11.15M -481M
Net Debt 7.09M 4.99M 4.38M 4.12M 3.77M 7.04M 478M 49.49M 19.19M 244M 18.76M 18.34M 791M -9.4M -6.62M -5.81M -5.46M -4.99M -9.33M -634M -65.59M -25.43M -323M -24.85M -24.31M -1.05B
Logo Exalt Resources Ltd
Adheris Health Ltd, formerly MedAdvisor Limited, is an Australia-based company engaged in offering pharmacy-driven patient engagement solutions that provide personalized patient experiences to help simplify the patient medication journey. Leveraging THRiV, a cloud-based, artificial intelligence (AI)-enabled platform, the Company enables the pharmacy with an improved pharmacy workflow and patient engagement solutions. THRiV analyzes hundreds of data points, from prescription history to socioeconomic factors, to anticipate patient needs. This technology allows the Company to deliver personalized strategies tailored to each individual. Its integrated platform provides users to manage, distribute and access medication information, including product information (PIs), consumer medicine information (CMIs) or patient leaflets (PL), instructions for use (IFUs) leaflets or videos, in real time.
Employees
-